-
Jiangsu Aidea Pharmaceutical Partners with Fidson Healthcare for HIV/AIDS Treatments in Nigeria
•
China-based Jiangsu Aidea Pharmaceutical Co., Ltd (SHA: 688488) has reportedly entered into a strategic cooperation agreement with Nigeria-based Fidson Healthcare plc. The partnership aims to facilitate the import of innovative HIV/AIDS therapies into Nigeria, a country with a significant population of 1.9 million HIV-infected individuals. Multi-Layered Collaboration on HIV/AIDS TreatmentsThe…
-
GE Healthcare’s Shanghai Innovation Hub Onboards Initial Start-Ups
•
GE Healthcare’s (NASDAQ: GEHC) newly established Shanghai innovation center, dedicated to advancing healthcare projects, has onboarded its first four start-ups. The selected companies include Ronovo Surgical, a manufacturer of abdominal surgery robots; MiDIVI, a developer of extended reality technology; RayShape Medical Technology, specializing in artificial intelligence ultrasound imaging diagnostics; and…
-
BeiGene’s Brukinsa Secures Additional EU Approval for Follicular Lymphoma Treatment
•
BeiGene Ltd (NASDAQ: BGNE; HKG: 6160; SHA: 688235) has achieved its latest global approval for the Bruton’s tyrosine kinase (BTK) inhibitor, Brukinsa (zanubrutinib). The European Commission has approved Brukinsa in combination with obinutuzumab (Roche’s CD20-targeted Gazyva) as a third-line treatment for relapsed or refractory (R/R) follicular lymphoma (FL). This marks…
-
WuXi Biologics’ Subsidiary WuXi XDC Lists on Hong Kong Stock Exchange
•
WuXi Biologics (HKG: 2269) has successfully spun off its conjugate drug-focused subsidiary, WuXi XDC Cayman Inc., (HKG: 2268) to the Hong Kong Stock Exchange on Friday, November 17, 2023. Through the global offer, WuXi XDC issued 178.44 million shares at a price of HK 20.60 per share. The gross proceeds…
-
Winning Health Partners with Shanghai Seventh People’s Hospital on Medical AI Services
•
Shanghai-based medical information industry player, Winning Health (SHE: 300253), has announced a partnership with Shanghai Seventh People’s Hospital to focus on medical artificial intelligence (AI) services. Collaboration on Medical AI Development and ApplicationThe collaboration aims to deepen research and development, application, and implementation of medical AI technologies. Together, Winning Health…
-
Thermo Fisher Scientific Expands Partnership with Sangon Biotech to Include GC/MS
•
US-based life sciences giant Thermo Fisher Scientific Inc., (NYSE: TMO) has announced an expansion of its strategic partnership with China-based contract research organization (CRO) Sangon Biotech. This development builds upon their initial agreement signed in August 2023, which now encompasses gas chromatography-mass spectrometry (GC/MS) in addition to the gene science…
-
Usynova Pharmaceuticals Inks Licensing Deal with AstraZeneca for KRASG12D Inhibitor UA022
•
Shanghai-based Usynova Pharmaceuticals Ltd has announced a licensing agreement with UK pharmaceutical major AstraZeneca (AZ, NASDAQ: AZN) concerning its pipeline candidate, UA022. UA022 is a small-molecule drug targeting the KRASG12D mutation, currently in the pre-clinical stages of development. Terms of the Agreement and FinancialsUnder the agreement, AstraZeneca (AZ) will secure…
-
Ascentage Pharma Secures Additional Indication Approval for Olverembatinib from NMPA
•
China-based Ascentage Pharma (HKG: 6855) has announced receiving another indication approval from the National Medical Products Administration (NMPA) for its Category 1 drug, olverembatinib. This second market-approved indication is for the treatment of adult patients with chronic myeloid leukemia (CML) in the chronic phase (CP) who are resistant and/or intolerant…
